AAREY DRUGS & PHARM LTD Share Price

NSE: AAREYDRUGS

S Cap

₹ 83.00

-₹0.10 (-0.12%)

Last updated 13 Aug, 2026, 15:27 IST

AAREY DRUGS & PHARM LTD Share Price Today

As of 14 Aug 2026, AAREY DRUGS & PHARM LTD share price is ₹83.00. The stock opened at ₹83.10, compared to its previous close of ₹83.10. During today's trading session, AAREY DRUGS & PHARM LTD share price moved in the range of ₹81.10 to ₹85.15, with an average price of ₹83.13 for the day. Looking at its last 52-week, the stock has touched a low of ₹50.31 and a high of ₹100.00. On the performance front, AAREY DRUGS & PHARM LTD share price has increased by 26.14% over the last six months and is up 30.97% on a year-on-year basis.

₹81.10

0.12% down today

₹85.15

1D LOW

1D HIGH

Stock Performance

OutperformingBeat Nifty by 1.44 % in last 1 month

Shareholding Pattern

FIIFII increased stake by 15.06%

AAREY DRUGS & PHARM LTD Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹6,30,699+₹1,30,699 (+26.14%)

3 Year

₹8,75,527+₹3,75,527 (+75.11%)

5 Year

₹11,06,667+₹6,06,667 (+121.33%)

₹78.95₹87.25

Circuit Low

Circuit High

₹50.31₹100.00

52-Week Low

52-Week High

Circuit

₹78.95

₹87.25

52-week

₹50.31

₹100.00

About AAREY DRUGS & PHARM LTD

ISIN

INE198H01019

Sector Market Cap

₹ 255.73 Cr

Aarey Drugs and Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing and trading of drugs and pharmaceuticals. The Company is in active pharmaceutical ingredients (API)/bulk drug manufacturing and offers a range of products for various industrial applications. Its products include N-Methyl Urea, Mefenamic acid, Doxofylline, Lumefantrine, Nimesulide, Albendazole, Carbamazepine and Oxcarbazepine. The Company's chemical and solvents include Aeromatics Chemical, Chemical acid, Chlor Alkali, Industrial Alchols, Industrial Ketones, Glycols and Glycol Ethers, Fiber Intermediates, Industrial Amines, Acetates and Esters, Industrial Oleochemicals, Industrial Intermediates, Chlorinated Solvents, Industrial Olefines, Industrial Phosphates, Industrial Fertilizers, Industrial Monomers and Industrial Chemicals. Its chemical acid products include Acetic acid, Citric acid, Formic acid and Hydrochloric acid.

AAREY DRUGS & PHARM LTD Financial Highlights

Revenue: AAREY DRUGS & PHARM LTD reported revenue of ₹478.37 crore in FY26 vs ₹483.75 crore in FY25. It showed a decrease of 1.11% on a yearly basis.
Operating Profit: AAREY DRUGS & PHARM LTD reported an operating profit of ₹5.41 crore in FY26 vs ₹6.10 crore in FY25. It showed a decrease of 11.31% on a year-on-year basis.
Net Profit: AAREY DRUGS & PHARM LTD reported a net profit of ₹3.97 crore in FY26 vs ₹4.02 crore in FY25. It showed a decrease of 1.24% on a yearly basis.

AAREY DRUGS & PHARM LTD Quarterly Result Highlights

AAREY DRUGS & PHARM LTD reported revenue of ₹189.04 crore in Mar 2026, compared with ₹100.61 crore in Dec 2025, representing an increase of 87.89% on a quarter-on-quarter (QoQ) basis.
AAREY DRUGS & PHARM LTD reported an operating profit of ₹1.28 crore in Mar 2026, compared with ₹0.92 crore in Dec 2025, representing an increase of 39.13% on a quarter-on-quarter (QoQ) basis.
AAREY DRUGS & PHARM LTD reported a profit of ₹1.56 crore in Mar 2026, compared with ₹0.57 crore in Dec 2025, reflecting an increase of 173.68% on a QoQ basis.
The earnings per share (EPS) of AAREY DRUGS & PHARM LTD stood at ₹1.42 during Mar 2026.

Know more

Promoters

37.71%

FII

4.80%

Other DII

1.62%

Retail and other

55.86%

Mutual funds

0.00%

Foreign institutions - FII

FII shareholding by period
Sep 2025	1.13%
Dec 2025	3.86%
Mar 2026	4.18%
Jun 2026	4.80%

Mkt Cap Cr

255.73

P/E

65.69

P/B

1.57

ROE

2.64%

D/E

0.33

ROCE

5.20%

Div. Yield

0.00%

EPS(TTM)

1.39

Turnover

3.10

EV/EBITDA

23.55

Net Margin

0.00%

Op. Margin

0.00%

ROA

1.52%

Quick Ratio

0.00

Curr. Ratio

2.74

Mkt Cap Cr

255.73

P/E

65.69

P/B

1.57

ROE

2.64%

D/E

0.33

ROCE

5.20%

Div. Yield

0.00%

EPS(TTM)

1.39

Turnover

3.10

EV/EBITDA

23.55

Net Margin

0.00%

Op. Margin

0.00%

ROA

1.52%

Quick Ratio

0.00

Curr. Ratio

2.74

Based on fundamentals, this stock's

Performance

Excellent

Aarey Drugs outperforming all market indices

Valuation

Overvalued

Aarey Drugs appears overvalued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,64,271.00	38.32	5.56	13.74%	0.61	17.33%	93.24	0.83%	0.48	10.90
Divis Laboratories	2,26,843.00	77.55	13.53	15.32%	0.00	19.56%	629.49	0.35%	0.55	98.19
Torrent Pharmaceuticals	1,86,000.00	86.27	22.12	25.49%	1.69	13.85%	222.76	0.69%	0.49	58.70
Zydus Lifesciences	1,20,099.00	26.15	4.43	18.59%	0.31	17.35%	237.30	0.08%	0.33	35.38
Cipla	1,18,027.00	35.18	3.43	11.27%	0.00	14.95%	423.36	0.89%	0.45	43.52
Lupin	1,03,549.00	18.65	4.61	23.76%	0.04	24.88%	659.05	0.79%	0.57	129.18
Mankind Pharma	1,00,137.00	48.43	6.14	11.74%	0.34	13.13%	397.02	0.04%	0.44	49.37
Dr. Reddy's Laboratories	1,00,073.00	31.44	2.63	11.07%	0.18	12.54%	377.96	0.67%	0.41	38.68
Laurus Labs	99,474.20	91.23	18.77	16.77%	0.40	16.14%	97.20	0.11%	0.67	13.72
Aurobindo Pharma	96,700.60	26.06	2.55	9.25%	0.19	11.76%	391.14	0.24%	0.38	41.58

AAREY DRUGS & PHARM LTD Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹473.94	₹395.62	₹418.96	₹492.76
Other Income	₹9.81	₹6.96	₹2.73	₹2.67
Total Revenue	₹483.76	₹402.58	₹421.69	₹495.43
Total Expenses	₹477.65	₹397.24	₹415.68	₹485.39
Profit Before Tax	₹6.10	₹5.34	₹6.01	₹10.04
Tax	₹2.08	₹0.66	₹2.24	₹3.48
Profit After Tax	₹4.02	₹4.68	₹3.77	₹6.55
EPS - Basic	₹1.42	₹1.84	₹1.49	₹2.72
EPS - Diluted	₹10.00	₹10.00	₹1.49	₹2.72

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹6.10	₹5.34	₹6.01	₹10.03
Income before WC changes	₹12.71	₹10.75	₹10.45	₹14.02
Change in Assets	₹16.84	-₹11.09	-₹50.86	-₹7.39
Change in Liabilities	-₹17.34	-₹1.33	₹41.40	-₹2.54
Change in WC	-₹0.50	-₹12.42	-₹9.45	-₹9.93
Cash flow from Operations	₹10.30	-₹2.99	-₹1.28	₹0.50
Cash flow from Investing	-₹5.94	-₹1.70	₹0.44	-₹3.21
Cash flow from Financing	-₹4.48	₹5.58	₹1.35	₹2.25
Total Cash Flow	-₹0.12	₹0.89	₹0.51	-₹0.46
Cash (Start of the year)	₹1.59	₹0.71	₹0.19	₹0.65
Cash (End of the year)	₹1.47	₹1.59	₹0.71	₹0.19

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹24.98	₹20.71	₹20.72	₹26.35
Current Assets	₹265.61	₹282.59	₹270.61	₹218.82
Total Assets	₹290.59	₹303.29	₹291.32	₹245.17
Current Liabilities	₹149.21	₹166.55	₹168.14	₹126.74
Net Current Asset	₹116.40	₹116.04	₹102.47	₹92.08
Non-Current Liabilities	₹2.91	₹3.97	₹5.78	₹4.80
Equity Capital	₹138.48	₹132.77	₹117.41	₹113.64
Total Equity & Liabilities	₹290.59	₹303.29	₹291.32	₹245.17